Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MasterCard Inc (MA) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

MasterCard IncTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

MasterCard Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? MasterCard Inc trades at $606.33 (market cap $529.81B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: MasterCard Inc is far larger — about 294.3× Vir Biotechnology Inc. Common Stock's market cap, and MasterCard Inc pays a 0.58% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold MasterCard Inc for 135 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

MAVIR
Market Cap
$529.81B$1.80B
Volume
3,710,6951,782,836
Sector
FinancialsHealth
52-Week High
$604.80$11.78
52-Week Low
$471.55$5.12
Typical Hold Time
135 Days0 Days
Enterprise Value
$542.84B$1.36B
Dividend Yield
0.58%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MasterCard Inc

Mastercard (MA) trades at $604.80, up 1.63% with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with 2025 revenue of $32.79B and net income of $14.97B, maintaining impressive profit margins above 45%. Recent earnings beats and institutional buying activity support the positive outlook, while the company continues expanding digital payment infrastructure globally.

Mastercard presents a compelling growth opportunity with 80% analyst buy ratings and a $668.67 consensus price target. Key risks include payment industry disruption from stablecoins and AI-driven competitors. The stock's premium valuation (P/E 33.27) requires sustained execution, but strong cash flow generation and strategic positioning support long-term upside potential.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MA
45% Buy55% Sell
Avg holding period · 135 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About MasterCard Inc

Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.

Read more on MA →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →